Your browser doesn't support javascript.
loading
Structural basis of malaria RIFIN binding by LILRB1-containing antibodies.
Chen, Yiwei; Xu, Kai; Piccoli, Luca; Foglierini, Mathilde; Tan, Joshua; Jin, Wenjie; Gorman, Jason; Tsybovsky, Yaroslav; Zhang, Baoshan; Traore, Boubacar; Silacci-Fregni, Chiara; Daubenberger, Claudia; Crompton, Peter D; Geiger, Roger; Sallusto, Federica; Kwong, Peter D; Lanzavecchia, Antonio.
Afiliação
  • Chen Y; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Xu K; Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
  • Piccoli L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Foglierini M; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Tan J; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Jin W; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
  • Gorman J; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Tsybovsky Y; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Zhang B; Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
  • Traore B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Silacci-Fregni C; Electron Microscopy Laboratory, Cancer Research Technology Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Daubenberger C; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Crompton PD; Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, International Center of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Geiger R; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Sallusto F; Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.
  • Kwong PD; Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Lanzavecchia A; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Nature ; 592(7855): 639-643, 2021 04.
Article em En | MEDLINE | ID: mdl-33790470
ABSTRACT
Some Plasmodium falciparum repetitive interspersed families of polypeptides (RIFINs)-variant surface antigens that are expressed on infected erythrocytes1-bind to the inhibitory receptor LAIR1, and insertion of DNA that encodes LAIR1 into immunoglobulin genes generates RIFIN-specific antibodies2,3. Here we address the general relevance of this finding by searching for antibodies that incorporate LILRB1, another inhibitory receptor that binds to ß2 microglobulin and RIFINs through their apical domains4,5. By screening plasma from a cohort of donors from Mali, we identified individuals with LILRB1-containing antibodies. B cell clones isolated from three donors showed large DNA insertions in the switch region that encodes non-apical LILRB1 extracellular domain 3 and 4 (D3D4) or D3 alone in the variable-constant (VH-CH1) elbow. Through mass spectrometry and binding assays, we identified a large set of RIFINs that bind to LILRB1 D3. Crystal and cryo-electron microscopy structures of a RIFIN in complex with either LILRB1 D3D4 or a D3D4-containing antibody Fab revealed a mode of RIFIN-LILRB1 D3 interaction that is similar to that of RIFIN-LAIR1. The Fab showed an unconventional triangular architecture with the inserted LILRB1 domains opening up the VH-CH1 elbow without affecting VH-VL or CH1-CL pairing. Collectively, these findings show that RIFINs bind to LILRB1 through D3 and illustrate, with a naturally selected example, the general principle of creating novel antibodies by inserting receptor domains into the VH-CH1 elbow.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Microscopia Crioeletrônica / Receptor B1 de Leucócitos Semelhante a Imunoglobulina / Anticorpos / Antígenos de Protozoários Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant País/Região como assunto: Africa Idioma: En Revista: Nature Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Microscopia Crioeletrônica / Receptor B1 de Leucócitos Semelhante a Imunoglobulina / Anticorpos / Antígenos de Protozoários Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant País/Região como assunto: Africa Idioma: En Revista: Nature Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça